-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

EBV and Post-transplant Lymphoproliferative Disorder (PTLD): A Complex Relationship

Program: Education Program
Session: Not All Lymphadenopathy is Lymphoma: Lymphoproliferative Diseases of Immune Dysregulation
Hematology Disease Topics & Pathways:
Lymphomas, Diseases, Treatment Considerations, Lymphoid Malignancies
Saturday, December 7, 2024, 9:30 AM-10:45 AM

Rayne Rouce, MD

Texas Children's Hospital, Houston, TX

Disclosures: Rouce: Novartis: Honoraria; Pfizer: Consultancy.

See more of: Not All Lymphadenopathy is Lymphoma: Lymphoproliferative Diseases of Immune Dysregulation
See more of: Education Program
<< Previous Presentation | Next Presentation